Nanoform small is powerful logo Nanoform small is powerful logo
  • Contact Us
  • About Nanoform
    About Nanoform
    • Vision, mission and values
    • Organization
      Board of Directors
      CEO and Management Team
    • Success stories
    • Corporate Responsibility
  • Technology
    Technology
    • CESS®
      STARMAP®
    • Biologics
      Formulations
    • Case studies
  • Services
    Services
    • GMP Manufacturing
  • Corporate Governance
    Corporate Governance
    • Corporate Governance Statements
      General meeting
      Annual General Meeting 2022
      General meetings
    • The Board of Directors
      Board of Directors
      Duties of the Board of Directors
      Authorisations
      Board committees
      Remuneration of the Board
    • CEO and Management Team
      Remuneration
      Audit
      Internal Control and Risk Management
      Code of conduct
    • Articles of Association
      Insider administration
      Disclosure policy
      Transcations of managers
  • Investors
    Investors Investerare Sijoittajat
    • Financial Reports and Presentations
      Press releases
      Subscribe
    • Share and shareholders
      Share information
      Share capital development
      Certified Adviser
      Analyst Coverage
      Ownership structure
      Notifications of major shareholdings
      Manager Transactions
    • IPO 2020
    • Investor calendar
      Contact
    • Finansiella rapporter och presentationer
      Pressmeddelanden
      Prenumerera
    • Aktien och aktieägare
      Aktieinformation
      Aktiekapitalets utveckling
      Certified Adviser
      Analytiker
      Ägarstruktur
      Anmälan om betydande aktieägare
      Transaktioner utförda av personer i ledande ställning
    • Börsnotering
    • Investerarkalender
      Kontakt
    • Taloudelliset raportit ja esitykset
      Tiedotteet
      Tilaaminen
    • Osake ja osakkeeomistajat
      Tiedot osakkeesta
      Osakepääoman kehitys
      Hyväksytty neuvonantaja
      Analyytikot
      Omistusrakenne
      Ilmoitukset merkittävistä osakkeenomistajista
      Johtohenkilöiden liiketoimet
    • Listautuminen
    • Sijoittajakalenteri
      Yhteystiedot
  • Media
    Media
    • Press releases
      News
    • Pharmaceutical events
      Articles & videos
    • Subscribe
      Brochure
    • Contact
  • Careers
  • Contact

Success stories

  • nanoform-1
    July 14, 2022

    Nanoform and Pharmanovia to breathe new life into iconic medicines

  • nanoform
    May 6, 2022

    Nanoform’s collaboration with TargTex

  • nanoform-6
    May 4, 2022

    Nanoform launches “STARMAP[®] Online” placing AI-power at the fingertips of medicine developers

  • nanoform-usa-finland
    March 22, 2022

    Nanoform successfully completes new share issue raising EUR 25 million to prepare for GMP manufacturing in the USA

  • March 11, 2022

    Nanoform triples its GMP capacity and adds high potent handling (OEL <30 ng/m3) capabilities to its Helsinki facility to meet increasing demand.

  • nanoform-4
    November 17, 2021

    Nanoform wins Star of Innovation award at the European Small and Mid-Cap Awards 2021

  • nanoform-3
    September 29, 2021

    Nanoform receives funding to solve challenges for global health

  • nanoform-2
    September 9, 2021

    Nanoform technology delivers successful results for Herantis CDNF drug candidate

  • nanoform-5
    August 3, 2021

    Nanoform and Boehringer Ingelheim execute master services agreement

  • May 18, 2021

    Nanoform’s final clinical results confirm value proposition to the pharma industry

  • May 4, 2020

    Nanoform awarded GMP certification

  • November 6, 2019

    Nanoform wins the CPhI Excellence in Pharma Award for Formulation

Contact us

+358 29 370 0150
info@nanoform.com

  • Privacy notice
  • Cookies

Subscribe

Read more about our protection of your personal data.

Nanoform Finland Oyj
Cultivator II, Viikinkaari 4
FI-00790 Helsinki
Finland
Company number: 2730572-8